Troels holds a master’s degree in pharmacy and his primary expertise has been in the areas of pharma for the last 15 years and the latest 5+ with digital transformations of radical and incremental nature. Troels is personally driven by identifying growth areas and driving the adoption of emerging technologies from idea to TRUE implementation and business value generation and very passionate about cultivating innovation and helping people in creating new and innovative solutions.
Troels first started working in a global function of regulatory affairs, International Drug Safety and followed by a role as clinical trial manager in clinical trial operations at Nycomed (now part of Takeda).
In 2011 Troels moved to LEO Pharma A/S, Denmark as Head of Department, PV Science in R&D with the overall focus to set and direct global Safety Risk Management and surveillance strategies and processes to ensure global regulatory compliance and business excellence. Moreover the position includes accountability to establish & implement effective governance structures to manage, minimize and communicate safety risks across the international LEO product portfolio. In August 2015 Troels took the overall responsibility for regulatory affairs, pharmacovigilance and compliance within a newly established innovation unit (https://leoinnovationlab.com/) which had the aim of building digital solutions that address the challenges fo the modern patient journey.
In 2019 Troels took up the role as VP, R&D Data and analytics at LEO Pharma. R&D Data and analytics is a function with the main purpose is to establish the digital capabilities which will facilitates the data and digital transformation to enable data utilization, advanced analytics and digital technologies to enable new discoveries and support operational excellence.
